dcth, WILL GET PRIORITY REVIEW FOR SURE..GREAT RESULTS IN CANCER PATIENTS, WHY NOT IT WILL GET PRIORITY REVIEW. GREAT COMPANY WITH GREAT php TECHNOLOGY
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.